Efficacy and Safety of Topical Resorcinol 15% as Long-Term Treatment of Mild–Moderate Hidradenitis Suppurativa
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Topical Resorcinol 15% as Long-Term Treatment of Mild-Moderate Hidradenitis Suppurativa: A Valid Alternative to Clindamycin in the Panorama of Antibiotic Resistance
Br J Dermatol 2020 Jun 24;[EPub Ahead of Print], E Molinelli, V Brisigotti, O Simonetti, A Campanati, C Sapigni, GM D'Agostino, A Giacchetti, C Cota, A OffidaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.